This chapter discusses the potential use of psychedelics and other compounds in joint therapy for autism, exploring the concept of metaplasticity and its relation to Fragile X. It also examines the role of metabotropic glutamate receptors and the closure of critical periods in autism, while expressing caution about the need for further research before implementing psychedelics as a therapy option.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode